135 related articles for article (PubMed ID: 30936069)
1.
Douglas SPM; Siipola P; Kovanen PE; Pyörälä M; Kakko S; Savolainen ER; Salmenniemi U; Orte K; Kytölä S; Pitkänen E; Porkka K; Kilpivaara O; Wartiovaara-Kautto U
Blood; 2019 Jun; 133(25):2724-2728. PubMed ID: 30936069
[No Abstract] [Full Text] [Related]
2. The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia.
Hakkarainen M; Kaaja I; Douglas SPM; Vulliamy T; Dokal I; Soulier J; Larcher L; Peffault de Latour R; Leblanc T; Sicre de Fontbrune F; Siitonen T; Lohi O; Hellström-Lindberg E; Barbany G; Tesi B; Shimamura A; Beier F; Jackson S; Kuperman AA; Falik Zaccai T; Tamary H; Mecucci C; Capolsini I; Jahnukainen K; Salmenniemi U; Niinimäki R; Varilo T; Kilpivaara O; Wartiovaara-Kautto U
Blood; 2023 Jun; 141(23):2853-2866. PubMed ID: 36952636
[TBL] [Abstract][Full Text] [Related]
3. Familial predisposition of myeloid malignancies: biological and clinical significance of recurrent germ line mutations.
Matsui H
Int J Hematol; 2017 Aug; 106(2):160-162. PubMed ID: 28631176
[No Abstract] [Full Text] [Related]
4. ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution.
Baccelli F; Leardini D; Cerasi S; Messelodi D; Bertuccio SN; Masetti R
Ann Hematol; 2023 Apr; 102(4):699-705. PubMed ID: 36790458
[TBL] [Abstract][Full Text] [Related]
5. Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation.
Renneville A; Mialou V; Philippe N; Kagialis-Girard S; Biggio V; Zabot MT; Thomas X; Bertrand Y; Preudhomme C
Leukemia; 2009 Apr; 23(4):804-6. PubMed ID: 18946494
[No Abstract] [Full Text] [Related]
6. Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.
Lewinsohn M; Brown AL; Weinel LM; Phung C; Rafidi G; Lee MK; Schreiber AW; Feng J; Babic M; Chong CE; Lee Y; Yong A; Suthers GK; Poplawski N; Altree M; Phillips K; Jaensch L; Fine M; D'Andrea RJ; Lewis ID; Medeiros BC; Pollyea DA; King MC; Walsh T; Keel S; Shimamura A; Godley LA; Hahn CN; Churpek JE; Scott HS
Blood; 2016 Feb; 127(8):1017-23. PubMed ID: 26712909
[TBL] [Abstract][Full Text] [Related]
7. Exome sequencing identifies an MLL3 gene germ line mutation in a pedigree of colorectal cancer and acute myeloid leukemia.
Li WD; Li QR; Xu SN; Wei FJ; Ye ZJ; Cheng JK; Chen JP
Blood; 2013 Feb; 121(8):1478-9. PubMed ID: 23429989
[No Abstract] [Full Text] [Related]
8. Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment.
Armes H; Bewicke-Copley F; Rio-Machin A; Di Bella D; Philippe C; Wozniak A; Tummala H; Wang J; Ezponda T; Prosper F; Dokal I; Vulliamy T; Kilpivaara O; Wartiovaara-Kautto U; Fitzgibbon J; Rouault-Pierre K
Br J Haematol; 2022 Dec; 199(5):754-764. PubMed ID: 36156210
[TBL] [Abstract][Full Text] [Related]
9. GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML.
Al Seraihi AF; Rio-Machin A; Tawana K; Bödör C; Wang J; Nagano A; Heward JA; Iqbal S; Best S; Lea N; McLornan D; Kozyra EJ; Wlodarski MW; Niemeyer CM; Scott H; Hahn C; Ellison A; Tummala H; Cardoso SR; Vulliamy T; Dokal I; Butler T; Smith M; Cavenagh J; Fitzgibbon J
Leukemia; 2018 Nov; 32(11):2502-2507. PubMed ID: 29749400
[No Abstract] [Full Text] [Related]
10. Germ line predisposition to myeloid malignancies appearing in adulthood.
Crysandt M; Brings K; Beier F; Thiede C; Brümmendorf TH; Jost E
Expert Rev Hematol; 2018 Aug; 11(8):625-636. PubMed ID: 29958021
[TBL] [Abstract][Full Text] [Related]
11. Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.
Király AP; Kállay K; Gángó A; Kellner Á; Egyed M; Szőke A; Kiss R; Vályi-Nagy I; Csomor J; Matolcsy A; Bödör C
Pathol Oncol Res; 2018 Jan; 24(1):83-88. PubMed ID: 28357685
[TBL] [Abstract][Full Text] [Related]
12. Cancer predisposition syndromes associated with myeloid malignancy.
Quinn E; Nichols KE
Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
[TBL] [Abstract][Full Text] [Related]
13. A novel CCAAT/enhancer binding protein α germline variant in a case of acute myeloid leukemia.
Gutman JA; Hoffner B
Leuk Lymphoma; 2012 May; 53(5):1006-7. PubMed ID: 22066712
[No Abstract] [Full Text] [Related]
14. Myeloid neoplasms with germ line RUNX1 mutation.
Hayashi Y; Harada Y; Huang G; Harada H
Int J Hematol; 2017 Aug; 106(2):183-188. PubMed ID: 28534116
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of germline predisposition gene mutations in pediatric acute myeloid leukemia: Genetic background of pediatric AML.
Jeong D; Lee DS; Kim N; Choi S; Kim K; Kim SM; Im K; Park HS; Yun J; Lim KM; Park KS; Kang HJ; Ahn YO; Hwang SM
Leuk Res; 2019 Oct; 85():106210. PubMed ID: 31470354
[No Abstract] [Full Text] [Related]
16. Familial myelodysplasia and acute myeloid leukaemia--a review.
Owen C; Barnett M; Fitzgibbon J
Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
[TBL] [Abstract][Full Text] [Related]
17. Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia.
Li R; Sobreira N; Witmer PD; Pratz KW; Braunstein EM
Haematologica; 2016 Jun; 101(6):e228-31. PubMed ID: 26944477
[No Abstract] [Full Text] [Related]
18. Mutation of CEBPA in familial acute myeloid leukemia.
Smith ML; Cavenagh JD; Lister TA; Fitzgibbon J
N Engl J Med; 2004 Dec; 351(23):2403-7. PubMed ID: 15575056
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia.
Hahn CN; Brautigan PJ; Chong CE; Janssan A; Venugopal P; Lee Y; Tims AE; Horwitz MS; Klingler-Hoffmann M; Scott HS
Leukemia; 2015 Aug; 29(8):1795-7. PubMed ID: 25676417
[No Abstract] [Full Text] [Related]
20. Myeloid neoplasms with germline DDX41 mutation.
Cheah JJC; Hahn CN; Hiwase DK; Scott HS; Brown AL
Int J Hematol; 2017 Aug; 106(2):163-174. PubMed ID: 28547672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]